SureGene, PGXL Partner on PGx Test for Antipsychotic Drugs | GenomeWeb

This article has been updated to include information about a competing product in the market.

NEW YORK (GenomeWeb News) – Psychiatric molecular diagnostic firm SureGene today announced it is partnering with PGXL Laboratories to launch a five-gene test for determining which patients may be best candidates for the most widely used antipsychotics and antidepressants.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.